A prospective randomized trial on mycophenolate mofetil in risk penetrating keratoplasty

Trial Profile

A prospective randomized trial on mycophenolate mofetil in risk penetrating keratoplasty

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs Mycophenolate mofetil (Primary)
  • Indications Keratoplasty rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jul 2012 Additional trial identifier 116-00 identified as reported by German Clinical Trials Register.
    • 25 Aug 2011 Actual initiation date (13 Sep 2000) added as reported by German Clinical Trials Register.
    • 25 Aug 2011 New source identified and integrated (German Clinical Trials Register DRKS00000011).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top